Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance.
Roy HuurmanNikki van der VeldeArend F L SchinkelH Carlijne HassingRicardo P J BuddeMarjon A van SlegtenhorstJudith M A VerhagenAlexander HirschMichelle MichelsPublished in: European heart journal. Cardiovascular Imaging (2022)
CMR reclassified 27% of subjects. Subjects with normal ECG/TTE results were reclassified in a low number of cases, justifying screening with ECG and TTE in G+ relatives. In subjects with abnormal ECGs and/or poor TTE image quality, CMR is indicated.